Hypersensitivity, Immediate: all 65 studies

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy PatientsNot yet recruitingNCT07891780Phase 2
• Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic DermatitisRecruitingNCT07316465Not applicable
• Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral ChallengesRecruitingNCT07038746Phase 1
• Risk-stratified Testing for Safe Removal of Penicillin Allergy LabelsRecruitingNCT06755281Not applicable
• Assessment of Er:YAG Laser for the Control of Hypersensitivity During Tooth Whitening With Hydrogen PeroxideNot yet recruitingNCT06538129Not applicable
• Optimization of the Skin Test Procedure With Iodinated Contrast Products for Certain Patients Suspected of Immediate HypersensitivityRecruitingNCT06498219
• Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating RoomRecruitingNCT05420935Not applicable
• BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaRecruitingNCT05341726Not applicable
• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT03720470Phase 3Results posted
• Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 2Results posted
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsCompletedNCT03627767Phase 3Results posted
• Effect of Benralizumab in Atopic DermatitisCompletedNCT03563066Phase 2Results posted
• Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic DermatitisCompletedNCT03054428Phase 3Results posted
• Asthma Data Innovation Demonstration ProjectCompletedNCT02162576Not applicableResults posted
• Peanut Epicutaneous Phase II Immunotherapy Clinical TrialCompletedNCT01904604Phase 2Results posted
• A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut AllergyCompletedNCT01084174Phase 1/2Results posted
• A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy TrialCompletedNCT00580606Phase 1/2Results posted
• Oral Immunotherapy for Childhood Egg AllergyCompletedNCT00461097Phase 2Results posted
• A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 1
• Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test ApplicatorsCompletedNCT07400718Not applicable
• Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult VolunteersCompletedNCT06963411Phase 1
• A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic AsthmaTerminatedNCT06592768Phase 1
• Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral ChallengesCompletedNCT06445374Phase 1
• Standardised Drug Provocation Testing in Perioperative HypersensitivityCompletedNCT06065137Not applicable
• Kenota 1 CWS Method Comparison Validation StudyCompletedNCT05702671
• Norwegian Birch Rust Allergy StudyCompletedNCT05661812
• 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)CompletedNCT05634746Phase 3
• Expanded Access Protocol for Patients With Eosinophilic EsophagitisNo longer availableNCT05095116
• Allergic Disease Onset Prevention StudyCompletedNCT05003804Phase 1/2
• Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of NancyStatus unknownNCT04920721
• The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin ChallengeCompletedNCT04454229Not applicable
• Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy During Autumn?CompletedNCT04322838
• Clinical Determinants and Perioperative Allergic Reactions (CADECAP Study)CompletedNCT03918772
• A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise HealthyStatus unknownNCT03819881Phase 1
• Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast AgentsCompletedNCT03525496
• A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and SpecialistsCompletedNCT02916888
• Comparison of Difference Histamine Concentration (1, 5 and 10 mg/ml) for Skin Prick Test Positive ControlCompletedNCT02561429Not applicable
• Comparison Between spIgE and Skin Prick Test of Local and Imported AeroallergensCompletedNCT02561390Not applicable
• The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom ImmunotherapyCompletedNCT02503800
• Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)CompletedNCT02163122Early Phase 1
• Diagnosis and Physiopathology of Insulin AllergyCompletedNCT01407640Not applicable
• A Study to Compare the Effects of Different Sized Particles on Cells in the NoseCompletedNCT01257191Phase 1
• Safety of Ertapenem in Beta-lactam Allergic Patients.Status unknownNCT01159379Phase 4
• Pathogenesis of Physical Induced Urticarial SyndromesCompletedNCT00887939
• Peanut Allergy Vaccine Study in Healthy and Peanut-allergic AdultsCompletedNCT00850668Phase 1
• Role of Skin Tests for the Diagnosis of Immediate Hypersensitivity Reactions Due to Iodinated Contrast MediaCompletedNCT00819494Not applicable
• Efficacy and Safety/Tolerability of Ragweed MATA MPLCompletedNCT00423787Phase 3
• Efficacy and Safety/Tolerability of Grass MATA MPLCompletedNCT00414141Phase 3
• Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic RhinitisTerminatedNCT00387478Phase 2
• Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic RhinitisCompletedNCT00325338Phase 2
• Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen OxideStatus unknownNCT00312312Not applicable
• Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick TestCompletedNCT00258635Phase 2
• Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen AllergenCompletedNCT00241410Phase 1
• Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass PollenCompletedNCT00133159Phase 2
• Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy VaccineCompletedNCT00133146Phase 2
• Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy VaccineCompletedNCT00118625Phase 2
• Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree PollenCompletedNCT00118612Phase 2
• Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick TestingCompletedNCT00116285Phase 1
• Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree PollenCompletedNCT00113750Phase 2
• Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed AllergyCompletedNCT00110786Phase 2
• Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)WithdrawnNCT00109759Phase 1
• Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick TestingCompletedNCT00107705Phase 1
• Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick TestingCompletedNCT00104390Phase 1
• Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye PollenCompletedNCT00104377Phase 2
• Clinical and Immunological Evaluation of Children With AllergiesCompletedNCT00102570

← Hypersensitivity, Immediate overview